Search research articles
Contact Us
Filters
Showing results (431-440 of 464) with videos related to
Page
of 47
Sort By:
Clinical Neurology and Neurosurgery
|
October 15, 2013
Outcome of lesionectomy in medically refractory epilepsy due to non-mesial temporal sclerosis (non-MTS) lesions
Vikas Dhiman, Sudhanva Rao, Sanjib Sinha, et al.
Journal of the Neurological Sciences
|
April 5, 2014
Clinico-pathological factors influencing surgical outcome in drug resistant epilepsy secondary to mesial temporal sclerosis
B V Savitr Sastri, A Arivazhagan, Sanjib Sinha, et al.
Scientific Reports
|
August 29, 2018
S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer's Disease
Chao Wang, Igor A Iashchishyn, Jonathan Pansieri, et al.
Indian Journal of Psychiatry
|
March 3, 2018
Early stages of Alzheimer's disease are alarming signs in injury deaths caused by traffic accidents in elderly people (≥60 years of age): A neuropathological study
Printha Wijesinghe, Catherine Gorrie, S K Shankar, et al.
Molecular Imaging and Biology
|
October 17, 2018
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 3, 2006
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Lalitha K Shankar, John M Hoffman, Steve Bacharach, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 14, 2017
High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine
M R Panasevich, G M Meers, M A Linden, et al.
Molecular Imaging and Biology
|
October 31, 2013
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC)
Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Journal of the National Cancer Institute
|
June 13, 2024
Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review
Lyndsay Harris, Lalitha K Shankar, Claire Hildebrandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents
Janet E Dancey, Kevin K Dobbin, Susan Groshen, et al.
Page
of 47
Search research articles
Search
Showing results (431-440 of 464) with videos related to
Sort By:
Page
of 47
Clinical Neurology and Neurosurgery
|
October 15, 2013
Outcome of lesionectomy in medically refractory epilepsy due to non-mesial temporal sclerosis (non-MTS) lesions
Vikas Dhiman, Sudhanva Rao, Sanjib Sinha, et al.
Journal of the Neurological Sciences
|
April 5, 2014
Clinico-pathological factors influencing surgical outcome in drug resistant epilepsy secondary to mesial temporal sclerosis
B V Savitr Sastri, A Arivazhagan, Sanjib Sinha, et al.
Scientific Reports
|
August 29, 2018
S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer's Disease
Chao Wang, Igor A Iashchishyn, Jonathan Pansieri, et al.
Indian Journal of Psychiatry
|
March 3, 2018
Early stages of Alzheimer's disease are alarming signs in injury deaths caused by traffic accidents in elderly people (≥60 years of age): A neuropathological study
Printha Wijesinghe, Catherine Gorrie, S K Shankar, et al.
Molecular Imaging and Biology
|
October 17, 2018
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 3, 2006
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Lalitha K Shankar, John M Hoffman, Steve Bacharach, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 14, 2017
High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine
M R Panasevich, G M Meers, M A Linden, et al.
Molecular Imaging and Biology
|
October 31, 2013
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC)
Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Journal of the National Cancer Institute
|
June 13, 2024
Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review
Lyndsay Harris, Lalitha K Shankar, Claire Hildebrandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents
Janet E Dancey, Kevin K Dobbin, Susan Groshen, et al.
Page
of 47